We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FFIV:NASDAQF5, Inc. Analysis

Data as of 2026-03-11 - not real-time

$286.14

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

F5, Inc. is trading at $286.14, comfortably above its 20‑day (278.14) and 50‑day (272.90) moving averages while just shy of the 200‑day average (286.99), suggesting short‑term momentum but a neutral longer‑term trend. The MACD remains bullish (line 3.60 above signal 2.81) and the RSI at 57.7 indicates no immediate overbought pressure, while volume is on an upward trajectory. Support sits near $259.67 and resistance near $289.99, leaving limited upside before hitting a key ceiling. Fundamentals are solid: revenue grew 7.3% YoY to $3.14 B, gross margins exceed 81%, and ROE stands at 20.8%, positioning the company as a high‑margin software player. The forward PE of 17 is well below the industry average of 36.9, implying a relative valuation discount, yet the DCF fair value of $244.23 places the current price in overvalued territory. No dividend is paid, reflecting a growth‑oriented capital allocation strategy. Recent headlines flag multiple securities‑fraud lawsuits, injecting legal uncertainty that could weigh on sentiment. Conversely, a new partnership with WWT to accelerate AI adoption underscores a strategic growth catalyst. Balancing strong profitability and modest revenue expansion against legal headwinds and a price premium, the stock appears poised for a cautious approach. Investors should monitor the upcoming resistance level and any developments in the litigation for short‑term direction. Overall, the company’s cash cushion and low net debt provide a defensive buffer while the market prices in optimistic growth expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at $289.99
  • Ongoing securities‑fraud litigation
  • Bullish MACD but high 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 7.3% revenue growth with >80% gross margin
  • Forward PE of 17 versus industry 36.9
  • Strategic AI partnership with WWT

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash position and net‑debt advantage
  • DCF fair value ($244) below current price
  • Potential resolution of legal risks

Key Metrics & Analysis

Financial Health

Revenue Growth7.30%
Profit Margin22.45%
P/E Ratio23.7
ROE20.84%
ROA8.09%
Debt/Equity7.57
P/B Ratio4.6
Op. Cash Flow$906.1M
Free Cash Flow$681.6M
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI57.7
Support$259.67
Resistance$289.99
MA 20$278.14
MA 50$272.90
MA 200$286.99
MACDBullish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value$244.23
Target Price$310.30
Upside/Downside8.44%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.04
Volatility43.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.